We are live on ! Find out more
VKH

Virtu KCG Holdings Portfolio holdings

AUM $3.6B
1-Year Est. Return 17.11%
This Fund
S&P 500
This Quarter Est. Return
+1.94%
1 Year Est. Return
+17.11%
3 Year Est. Return
+11.98%
5 Year Est. Return
10 Year Est. Return
AUM
$5.88B
AUM Growth
-$234M
Cap. Flow
-$451M
Cap. Flow %
-7.68%
Top 10 Hldgs %
31.03%
Holding
4,421
New
1,120
Increased
1,147
Reduced
1,150
Closed
960

Sector Composition

Rank Sector Weight
1 Financials 3.99%
2 Technology 2.96%
3 Consumer Discretionary 2.95%
4 Industrials 2.84%
5 Healthcare 2.8%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CVO
3126
DELISTED
Cenevo, Inc.
CVO
$57K ﹤0.01%
+8,120
New +$104K
ICLD
3127
DELISTED
INTERCLOUD SYSTEMS, INC. COMMON STOCK
ICLD
$57K ﹤0.01%
57,045
+43,075
+308% +$62.5K
CVGI icon
3128
Commercial Vehicle Group
CVGI
$154M
$56K ﹤0.01%
+20,200
New +$72.6K
SHYF
3129
DELISTED
The Shyft Group
SHYF
$56K ﹤0.01%
+17,946
New +$69.6K
SPRT
3130
DELISTED
support.com, Inc.
SPRT
$56K ﹤0.01%
18,485
+12,363
+202% +$42.3K
BBG
3131
DELISTED
Bill Barrett Corp
BBG
$56K ﹤0.01%
14,198
-10,590
-43% -$54.4K
DRRX
3132
DELISTED
DURECT Corp
DRRX
$55K ﹤0.01%
2,483
-160
-6% -$3.46K
TROX icon
3133
Tronox
TROX
$932M
$55K ﹤0.01%
+14,048
New +$77.3K
VJET
3134
DELISTED
VOXELJET AG American Depositary Shares (each representing one Ordinary Share)
VJET
$55K ﹤0.01%
+2,461
New +$68.2K
CATX icon
3135
Perspective Therapeutics
CATX
$332M
$54K ﹤0.01%
5,761
+3,341
+138% +$41.6K
SINT icon
3136
SiNtx Technologies
SINT
$10.8M
0
SLNO
3137
DELISTED
Soleno Therapeutics
SLNO
$54K ﹤0.01%
392
+233
+147% +$34.1K
NPKI
3138
NPK International
NPKI
$1.06B
$54K ﹤0.01%
10,149
-12,277
-55% -$70.8K
NYMX
3139
DELISTED
Nymox Pharmaceutical Corp
NYMX
$54K ﹤0.01%
+16,572
New +$55.6K
MPVD
3140
DELISTED
Mountain Province Diamonds Inc.
MPVD
$54K ﹤0.01%
18,878
-14,930
-44% -$43K
FGH
3141
DELISTED
FG Group Holdings Inc.
FGH
$53K ﹤0.01%
11,429
+1,390
+14% +$6.27K
ALU
3142
CALL
DELISTED
Alcatel-Lucent
ALU
$53K ﹤0.01%
13,800
+3,300
+31% +$12.7K
CAS
3143
DELISTED
A M Castle & Co
CAS
$53K ﹤0.01%
+33,299
New +$81.3K
CANF
3144
Can-Fite BioPharma American Depositary Shares
CANF
$6.75M
$52K ﹤0.01%
6
+1
+20% +$10.1K
FOCL
3145
EDAP TMS S.A.
FOCL
$229M
$52K ﹤0.01%
12,622
-23,289
-65% -$111K
IRD
3146
Opus Genetics
IRD
$306M
$52K ﹤0.01%
298
-70
-19% -$14.9K
ENZ
3147
DELISTED
Enzo Biochem, Inc.
ENZ
$52K ﹤0.01%
+11,492
New +$48.5K
BIOC
3148
DELISTED
Biocept, Inc.
BIOC
$52K ﹤0.01%
1
FCSC
3149
DELISTED
Fibrocell Science Inc.
FCSC
$52K ﹤0.01%
756
-733
-49% -$52.7K
FATE icon
3150
Fate Therapeutics
FATE
$286M
$51K ﹤0.01%
+15,057
New +$63.3K

Similar funds

Virtu KCG Holdings's Q4 2015 Portfolio in Review

As of Q4 2015, Virtu KCG Holdings held 4,421 positions worth $5.88B, down 3.8% from $6.11B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Virtu KCG Holdings withdrew a net $451M in Q4 2015, closing 960 positions and reducing 1,150 holdings. Its most notable exit was Shire pic, an estimated $12.3M position sold in full.

By sector, the portfolio is most concentrated in Financials at 4% of assets, up from 3% a quarter earlier, followed by Technology and Consumer Discretionary.

Against the trend, Virtu KCG Holdings opened a new position in Guggenheim BulletShares 2016 High Yield Corporate Bond ETF worth $11.7M.

  • Virtu KCG Holdings's largest Q4 2015 buy was Guggenheim BulletShares 2016 High Yield Corporate Bond ETF: 453,312 shares worth $11.7M.
  • Virtu KCG Holdings added most to Berkshire Hathaway Class A in Q4 2015, an estimated $33.6M increase.
  • Virtu KCG Holdings's biggest Q4 2015 reduction was PIMCO Enhanced Short Maturity Active Exchange-Traded Fund, cutting an estimated $44.9M.
  • Virtu KCG Holdings fully exited Shire pic in Q4 2015, selling an estimated $12.3M.
  • Virtu KCG Holdings's ten largest holdings make up 31% of its $5.88B portfolio in Q4 2015.
  • Virtu KCG Holdings opened 1,120 new positions and closed 960 in Q4 2015.
  • Virtu KCG Holdings's portfolio value fell 3.8% quarter-over-quarter to $5.88B.

Based on Virtu KCG Holdings's 13F filing for Q4 2015, filed 12 Feb 2016.